Evidence map›Paper›PMID 26633653›Full record

ArticlePloS one2015

Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7.

Yu-Wen Chu, Shu-Ting Liu, Hsiao-Chun Cheng, Shih-Ming Huang, Yung-Lung Chang, Chien-Ping Chiang, Ying-Chun Liu, Wei-Ming Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yu-Wen ChuGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
Shu-Ting LiuBiochemistry Department, National Defense Medical Center, Taipei, Taiwan, ROC.
Hsiao-Chun ChengBiochemistry Department, National Defense Medical Center, Taipei, Taiwan, ROC.
Shih-Ming HuangBiochemistry Department, National Defense Medical Center, Taipei, Taiwan, ROC.
Yung-Lung ChangBiochemistry Department, National Defense Medical Center, Taipei, Taiwan, ROC.
Chien-Ping ChiangBiochemistry Department, National Defense Medical Center, Taipei, Taiwan, ROC.
Ying-Chun LiuSchool of Nursing, National Defense Medical Center, Taipei, Taiwan, ROC.
Wei-Ming WangGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
National Defense Medical Center · TWTri-Service General Hospital · TWNational Yang Ming Chiao Tung University · TWTaichung Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ZAC, an encoding gene mapped at chromosome 6q24-q25 within PSORS1, was previously found over-expressed in the lower compartment of the hyperplastic epidermis in psoriatic lesions. Cytokines produced in the inflammatory dermatoses may drive AP-1 transcription factor to induce responsive gene expressions. We demonstrated that mZac1 can enhance AP-1-responsive S100A7 expression of which the encoding gene was located in PSORS4 with HaCaT keratinocytes. However, the mZac1-enhanced AP-1 transcriptional activity was suppressed by curcumin, indicating the anti-inflammatory property of this botanical agent and is exhibited by blocking the AP-1-mediated cross-talk between PSORS1 and PSORS4. Two putative AP-1-binding sites were found and demonstrated to be functionally important in the regulation of S100A7 promoter activity. Moreover, we found curcumin reduced the DNA-binding activity of AP-1 to the recognition element located in the S100A7 promoter. The S100A7 expression was found to be upregulated in the lesioned epidermis of atopic dermatitis and psoriasis, which is where this keratinocyte-derived chemoattractant engaged in the pro-inflammatory feedback loop. Understanding the regulatory mechanism of S100A7 expression will be helpful to develop therapeutic strategies for chronic inflammatory dermatoses via blocking the reciprocal stimuli between the inflammatory cells and keratinocytes.

Indexed as

Cell Cycle ProteinsCell LineCurcuminHumansKeratinocytesPromoter Regions, GeneticReactive Oxygen SpeciesS100 Calcium Binding Protein A7S100 ProteinsTranscriptional ActivationTranscription Factor AP-1Transcription FactorsTumor Suppressor ProteinsUp-RegulationCell Cycle ProteinsCurcuminPLAGL1 protein, humanReactive Oxygen SpeciesS100A7 protein, humanS100 Calcium Binding Protein A7S100 ProteinsTranscription Factor AP-1Transcription FactorsTumor Suppressor Proteins

Identifiers

PMID26633653
PMCPMC4669192
OpenAlexW2190893255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.